pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
MB-204
Alzheimer's Disease
Marvel Biotechnology Inc
0
catalysts
Preclinical
MBP-091
Marburgvirus Infections (Marburg Hemorrhagic Fever)
Mapp Biopharmaceutical Inc
0
catalysts
Phase 1
MBP-134
Ebolavirus Infections (Ebola Hemorrhagic Fever)
Mapp Biopharmaceutical Inc
0
catalysts
Phase 1
MBQ-167
← prev
page 122 of 271
next →
131
Pain
89
Neurology
1
Triple-Negative Breast Cancer (TNBC)
MBQ Pharma Inc
0
catalysts
Phase 1
MBX-4291
Obesity
$MBX
MBX Biosciences, Inc.
0
catalysts
Phase 2
MC-001
Spinal Cord Injury
StemCyte Inc
0
catalysts
Phase 3
MC-1
heart failure
$MCUJF
MEDICURE INC
0
catalysts
Preclinical
MC-16
Retinitis Pigmentosa (Retinitis)
Mitochem Therapeutics, LLC
0
catalysts
Phase 2
MC-232
Hidradenitis Suppurativa
MC2 Therapeutics AS
0
catalysts
Phase 1
MCLA-145
Solid Tumor
Merus NV
0
catalysts
Phase 1
MCM-998
Multiple Myeloma (Kahler Disease)
$NVS
NOVARTIS AG
0
catalysts
Preclinical
MCR-231
Neurotrophic Keratitis
MicroCures Inc
0
catalysts
Preclinical
MDC-STM
ivermectin
Malaria
MedinCell SA
0
catalysts
Preclinical
MDC-WWM
Female Contraception
MedinCell SA
0
catalysts
Phase 2
MDI-1228
Diabetic Foot Ulcers
Henan Maiyingnuo Pharmaceutical Technology Co Ltd
0
catalysts
Preclinical
MDL-101
Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD or LAMA2-Related Mu…
Modalis Therapeutics Corp
0
catalysts
Preclinical
MDL-204
Unspecified Central Nervous System Disorders
Modalis Therapeutics Corp
0
catalysts
Preclinical
MDMA Patch
Unspecified Psychiatric Disorders
PharmaTher Holdings Ltd
0
catalysts
Phase 2
MDNA-11
Solid Tumor
$MDNAF
Medicenna Therapeutics Corp.
0
catalysts
Phase 2
MDX-1097
Refractory Multiple Myeloma
HaemaLogix Pty Ltd
0
catalysts
Phase 1
MDX-2301
Coronavirus Disease 2019 (COVID-19)
ModeX Therapeutics Inc
0
catalysts
Preclinical
ME-101
Neonatal Respiratory Distress Syndrome
Molecular Express Inc
0
catalysts
Phase 1
MEB-1170
Pain
Mebias Discovery LLC
0
catalysts
Phase 2
MEDI-0457
Oropharyngeal Cancer
$AZN
ASTRAZENECA PLC
0
catalysts
MEGATOPE
MEGATOPE (IODINATED I-131 ALBUMIN)
ISO TEX
0
catalysts
Phase 1
MEI-004
Alopecia
Nanjing Mainowei Pharmaceutical Technology Co Ltd.
0
catalysts
MEKINIST
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE)
1 INDICATIONS AND USAGE MEKINIST is a kinase inhibitor indicated as a single…
Dual specificity mitogen-activated protein kinase kinase 2
Dual specificity mitogen-activated protein kinase kinase 1
$NVS
NOVARTIS AG
0
catalysts
Phase 1
MEM-288
Cutaneous Squamous Cell Carcinoma (cSCC)
Memgen Inc
0
catalysts
MEMANTINE
MEMANTINE (MEMANTINE)
DR REDDYS LABS LTD
0
catalysts
Preclinical
MEMPD-119
Parkinson's Disease
GB Sciences Inc
0
catalysts
